Company Overview Intra-Cellular Therapies (NASDAQ: ITCI) is a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders. The company’s primary product...
Stocks that traded heavily or had substantial price changes on Tuesday: UnitedHealth Group, Morgan Stanley rise; PNC Financial, Live Nation fall
The company's depression drug, Caplyta (lumateperone), did well in a phase 3 trial against two types of depression.
FN Media Group Presents USA News Group News Commentary  Vancouver, BC – March 15, 2023 – USA News Group  – According to a 2022 study of more than 6 million patients 65 and older, the risk factor...
USA News Group – According to a 2022 study of more than 6 million patients 65 and older, the risk factor for developing Alzheimer’s disease increases by 50-80% in older adults who caught COVID-19....